imipenem, anhydrous and Experimental Lung Inflammation
imipenem, anhydrous has been researched along with Experimental Lung Inflammation in 81 studies
Research
Studies (81)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (20.99) | 18.7374 |
1990's | 22 (27.16) | 18.2507 |
2000's | 13 (16.05) | 29.6817 |
2010's | 21 (25.93) | 24.3611 |
2020's | 8 (9.88) | 2.80 |
Authors
Authors | Studies |
---|---|
Carvalhaes, CG; Castanheira, M; Sader, HS; Shortridge, D | 1 |
Kline, EG; Samanta, P; Shields, RK; Stellfox, ME; Van Tyne, D | 1 |
Akrami, S; Alkhudhairy, MK; Benyagoub, E; Raouf, FEA; Saki, M | 1 |
Al-Madboly, LA | 1 |
Arends, SJR; Carvalhaes, CG; Castanheira, M; Mendes, RE; Sader, HS; Shortridge, D | 1 |
Abdurahim, SA; Alameen, AA; Aloufi, AS; Elsayim, R; Eltayb, WA; Modafer, Y | 1 |
He, A; He, L; Qian, Y | 1 |
Broquet, A; Burghelea, A; Caroff, N; Crémet, L; Delanou, S; Leroy, AG; Muller, D; Roquilly, A | 1 |
Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD | 1 |
Duan, M; Jie, L; Shi, W; Sun, W | 1 |
Jiang, C; Liu, L; Liu, N; Xie, N; Xu, Y; Zhang, G | 1 |
Kaniga, K; Lee, M; Redman, R; Rice, DA | 1 |
Hsueh, PR; Lai, CC; Liao, CH; Ruan, SY; Tsai, HY | 1 |
Ge, L; He, S; Huang, A; Jin, Y | 1 |
Yang, J; Zhao, K; Zhu, Y | 1 |
Ghebremedhin, B; Rasche, K; Yayan, J | 1 |
Chan, YJ; Chuang, C; Chuang, YC; Fung, CP; Huang, CT; Lin, YT; Siu, LK; Su, CF; Wang, LS | 1 |
Chen, TL; Chuang, MF; Huang, WC; Kuo, SC; Lauderdale, TL; Lee, Y; Tseng, KC; Yang, YS | 1 |
Ayerbe Algaba, R; Díaz, C; Gutiérrez Valencia, A; Jiménez Mejías, ME; López Cortés, LF; Pachón Ibáñez, ME; Pachón, J; Parra Millán, R; Pérez Del Palacio, J; Sánchez Encinales, V; Smani, Y | 1 |
Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K | 1 |
Compain, F; Guerot, E; Jarraud, S; Podglajen, I; Richaud, C; Rossi, B; Rostane, H | 1 |
Martin, SI; Moffatt-Bruce, S; Nunley, DR; Pope-Harman, A; Ross, P; Sopirala, MM | 1 |
Chuang, YC; Cooper, CA; Dartois, N; Datsenko, O; Dukart, G; Dzyublik, O; Freire, AT; Gandjini, H; Glumcher, F; Kim, MJ; Korth-Bradley, JM; Maroko, RT; Melnyk, V | 1 |
Apisarnthanarak, A; Apisarnthanarak, P; Kiratisin, P; Mundy, LM | 1 |
Amoros, F; Borrás-Blasco, J; Enriquez, R; Navarro-Ruiz, A; Padilla, S; Sirvent, AE; Solavera, J | 1 |
Kim, JS; Kim, NY; Lee, KJ; Park, JS; Yun, HK | 1 |
Balla, G; Bene, Z; Gaspar, I; Nagy, B; Papp, A; Voko, Z | 1 |
Lee, JH; Loh, TF | 1 |
Nagy, B | 1 |
Dartois, N; Gandjini, H; Korth-Bradley, J; McGovern, PC; Ramirez, J; Yan, JL | 1 |
Barrero-Almodóvar, AE; Bernabeu-WittelI, M; Gallego-Lara, SL; García-Garmendia, JL; Garnacho-Montero, J; Jiménez-Jiménez, FJ; Madrazo-Osuna, J; Ortiz-Leyba, C | 1 |
Agustí, C; Torres, A | 1 |
Xiang, XD; Yang, H; Yi, ZM | 1 |
Dünser, M; Hasibeder, W; Mayr, AJ; Rieger, M | 1 |
Bernabeu-Wittel, M; García-Curiel, A; Jiménez-Mejías, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
Amato, G; Bariffi, F; Giacomelli, P; Nani, E; Sanduzzi, A | 1 |
Leitner, E; Lode, H; Schmitt, DV; Welte, T | 1 |
Apezteguia, C; Baquero, S; Gando, S; Llerena, C; Lloria, M; Luna, CM; Maskin, B; Petrati, C; Rios, FG; Saenz Valiente, A; Sosa, C | 1 |
Brzoska, T; Klehmet, J; Meisel, A; Meisel, C; Quarcoo, D; Schulte-Herbrüggen, O | 1 |
Dowzicky, M; Kuti, JL; Nicolau, DP | 1 |
Barker, J; Chiodini, PL | 1 |
Johnson, CE; Pennington, JE | 1 |
Echávarri, B; Marco, ML; Remacha, A | 1 |
Carretero, J; Carrión, F; Escoms, R; Pedro, MV; Prat, J | 1 |
Baumgartner, JD; Chopart, P; Cometta, A; Eggimann, P; Herter, C; Huber, O; Lew, D; Pittet, D; Schaad, U; Zimmerli, W | 1 |
Caldwell, JW; Fink, MP; Heard, SO; Johnson, RH; Leeper, KV; Niederman, MS; Schentag, JJ; Siami, GA; Snydman, DR; Wunderink, RG | 1 |
Fujita, K; Hatae, Y; Kon-No, M; Nagashima, T; Nakadate, H; Suzuki, Y; Takahashi, Y; Takase, A; Takeda, T; Wagatsuma, Y | 1 |
Cunningham, J; Holt, RI; Kwan, JT; Sefton, AM | 1 |
Fink, M; Niederman, M; Reinhart, H; Snydman, D | 1 |
Demirel, M; Eskitürk, A; Haklar, G; Işgör, A; Peker, O; Söyletir, G; Yalçin, AS | 1 |
Cuschieri, P; Galizia, AC; Vassallo, J | 1 |
Horstkotte, D; Klein, RM; Kramer, A; Niehues, R; Schaal, KP; Schlüter, S; Strauer, BE | 1 |
Cheadle, WG; Fabian, T; Fry, DE; Gardner, SA; Kesterson, L; Livingston, DH; Malangoni, MA; Polk, HC; Trachtenberg, LS | 1 |
Hu, W; Li, J; Zhu, Y | 1 |
Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G | 1 |
Hidri, N; Jacolot, A; Leotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K | 1 |
Caballero, FJ; Cuberos, L; García-Curiel, A; Jiménez-Mejías, ME; Moreno, I; Pachón, J; Pichardo, C; Rodríguez-Hernández, MJ | 1 |
Briggs, A; Feldman, C; Flitcroft, A; O'Grady, J; Richards, G; White, H | 1 |
Berry, H; Bret, L; Di Martino, P; Gagnière, H | 1 |
Petrone, JA | 1 |
Kuroe, K; Nakaji, S; Ogasawara, H; Saito, S; Sakata, Y; Sawada, Y; Shinagawa, H; Soma, N; Takami, H; Tsushima, K | 1 |
Bonnotte, B; Caillot, D; Chavanet, P; Portier, H | 1 |
Asmus, S; Bodmann, KF; Hartenauer, U; Koch, EM; Ritzerfeld, WW; Weilemann, LS | 1 |
Bauernfeind, A; Bellido, F; Blaser, J; Pechère, JC; Veuthey, C | 1 |
Baetz, R; Borner, K; Lebahn, K; Lode, H; Olschewski, P; Reinke, M; Sievers, H; Wagner, J; Wiley, E; Wintermantel, M | 1 |
Dretler, RH; Job, ML | 1 |
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
Calame, W; Craig, WA; Ebert, S; Fantin, B; Leggett, JE; Mattie, H; Totsuka, K; Vogelman, B | 1 |
Lenhart, FP; Ruckdeschel, G; Unertl, K | 1 |
Forder, AA; Linton, DM; Plumb, H; Potgieter, PD | 1 |
Alvarez, ME; Bodey, GP; Elting, L; Fainstein, V; Jones, P; Rolston, K | 1 |
Fujita, K; Inyaku, F; Kakehashi, H; Maruyama, S; Murono, K; Ohmi, H; Sakata, H; Sanae, N; Yoshioka, H | 1 |
Roselle, GA | 1 |
Alvarez, ME; Bodey, GP; Fainstein, V; Jones, P; Rolston, K; Steelhammer, L | 1 |
Bertch, K; Foster, TS; Rapp, RP; Tibbs, P; Young, B | 1 |
Alvarez, ME; Bodey, GP; Fainstein, V; Jones, PG; Rolston, KV; Steelhammer, L | 1 |
Aebert, H; Bunzendahl, H; Hünefeld, G; Weissbrodt, H | 1 |
Duma, RJ; Gebhart, RL; Groschel, DH; Mandell, GL; Palmer, DL; Salata, RA; Scheld, WM; Wade, BH; Wenzel, RP | 1 |
Beasley, CR; Humble, MW; O'Donnell, TV | 1 |
Bagett, JW; Duma, RJ; Gebhart, RJ; Patterson, PM; Williams, DS | 1 |
Trials
18 trial(s) available for imipenem, anhydrous and Experimental Lung Inflammation
Article | Year |
---|---|
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Double-Blind Method; Drug Combinations; Hospital Mortality; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Pneumonia; Pneumonia, Ventilator-Associated; Tigecycline; Treatment Outcome | 2010 |
Efficacy of methylprednisolone in children with severe community acquired pneumonia.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; C-Reactive Protein; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Length of Stay; Leukocyte Count; Male; Methylprednisolone; Pneumonia; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Minocycline; Pneumonia; Tigecycline | 2013 |
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
Topics: Adult; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Penicillanic Acid; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam; Treatment Outcome | 2006 |
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients.
Topics: Adult; Aged; Bacteremia; Bacterial Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Netilmicin; Peritonitis; Pneumonia; Prospective Studies | 1994 |
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Hospitalization; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis; Seizures | 1994 |
[A multi-institutional study on the efficacy and toxicity of imipenem/cilastatin sodium in severe infections complicating hematological diseases and cancers in children. Study Group of Infectious Diseases in Pediatric Hematology/Oncology in Hokkaido].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Leukemia; Leukopenia; Male; Neoplasms; Pneumonia; Sepsis | 1993 |
Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin.
Topics: Aged; Anti-Infective Agents; APACHE; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Male; Middle Aged; Pneumonia; Prospective Studies | 1995 |
Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial.
Topics: Aztreonam; Bronchoalveolar Lavage Fluid; Cilastatin; Cross Infection; Drug Therapy, Combination; HLA-DR Antigens; Humans; Imipenem; Pneumonia; Prospective Studies; Respiration, Artificial; Vancomycin; Wounds and Injuries | 1997 |
[A randomized clinical study of sulperazone versus tienam in the treatment of LRTIS].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Sulbactam; Thienamycins | 1996 |
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam | 1998 |
An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Anti-Infective Agents; Cilastatin; Drug Administration Schedule; Female; Fever; Fluoroquinolones; Follow-Up Studies; Humans; Imipenem; Male; Middle Aged; Molecular Structure; Pneumonia; Protease Inhibitors; Thienamycins | 2001 |
[A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases].
Topics: Adolescent; Adult; Aged; Aztreonam; Cilastatin; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Lincomycin; Male; Middle Aged; Neoplasms; Opportunistic Infections; Pneumonia; Sepsis; Urinary Tract Infections | 1992 |
Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.
Topics: Ceftazidime; Cilastatin; Cross Infection; Drug Combinations; Female; Germany, West; Humans; Imipenem; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic; Respiration, Artificial; Sepsis | 1990 |
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Ofloxacin; Pneumonia; Prospective Studies; Remission Induction; Respiratory Tract Infections; Sepsis; Ticarcillin | 1990 |
Imipenem/cilastatin therapy of infections in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Leukemia; Male; Middle Aged; Neoplasms; Pneumonia; Sepsis; Thienamycins | 1987 |
Imipenem-cilastatin as initial therapy for febrile cancer patients.
Topics: Adult; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia; Sepsis; Thienamycins | 1986 |
Other Studies
63 other study(ies) available for imipenem, anhydrous and Experimental Lung Inflammation
Article | Year |
---|---|
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitalization; Humans; Imipenem; Jupiter; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
Evolution of Imipenem-Relebactam Resistance Following Treatment of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia; Pseudomonas aeruginosa | 2022 |
Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Humans; Imipenem; Iraq; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norfloxacin; Pneumonia | 2022 |
A Novel Triple Combination To Combat Serious Infections with Carbapenem-Resistant Acinetobacter baumannii in a Mouse Pneumonia Model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Ascorbic Acid; Biological Factors; Carbapenems; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Inflammation; Mice; Microbial Sensitivity Tests; Pneumonia; Transferrins | 2022 |
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020-2021).
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Hospitals; Humans; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2023 |
Molecular Dynamic Analysis of Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Humans; Imipenem; Klebsiella; Klebsiella pneumoniae; Ligands; Meropenem; Metal Nanoparticles; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Monobactams; Nanoparticles; Pneumonia; Porins; Spectroscopy, Fourier Transform Infrared; Zinc Oxide | 2023 |
Imipenem-resistant Pseudomonas aeruginosa treated with piperacillin/tazobactam in a patient with severe pneumonia: a case report and related literature review.
Topics: Aged; Female; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Tazobactam | 2021 |
Antibiotic resistance heterogeneity and LasR diversity within Pseudomonas aeruginosa populations from pneumonia in intensive care unit patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Bronchoalveolar Lavage; Ceftazidime; DNA, Bacterial; Drug Resistance, Bacterial; Genetic Variation; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Mutation; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Trans-Activators | 2021 |
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult | 2017 |
A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Blood Cell Count; Bone Marrow Examination; Cilastatin; Female; Humans; Hydroxychloroquine; Imipenem; Lung; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Pneumonia; Prednisolone; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Treatment with andrographolide sulfonate provides additional benefits to imipenem in a mouse model of Klebsiella pneumoniae pneumonia.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cell Movement; Disease Models, Animal; Diterpenes; Humans; Imipenem; Inflammation; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice, Inbred C57BL; Monocyte Chemoattractant Proteins; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; Survival Analysis; THP-1 Cells | 2019 |
Fatal pneumonia and empyema thoracis caused by imipenem-resistant Nocardia abscessus in a cancer patient.
Topics: Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Empyema, Pleural; Hemangiosarcoma; Humans; Imipenem; Immunocompromised Host; Male; Middle Aged; Multiple Organ Failure; Nocardia; Nocardia Infections; Pneumonia; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
[Clinical analysis of scrub typhus-associated hemophagocytic syndrome].
Topics: Anti-Bacterial Agents; Azithromycin; C-Reactive Protein; Clinical Laboratory Techniques; Diagnosis, Differential; Erythromycin; Humans; Imipenem; Lymphohistiocytosis, Hemophagocytic; Pneumonia; Retrospective Studies; Scrub Typhus | 2014 |
[Analysis of pathogen distribution and drug resistance in coal workers' pneumoconiosis associated with pneumonia].
Topics: Anthracosis; Anti-Bacterial Agents; Coal Mining; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Occupational Exposure; Pneumonia; Thienamycins | 2015 |
No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli.
Topics: Aged; Aged, 80 and over; Ampicillin Resistance; Escherichia coli; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Pneumonia; Quality Improvement; Retrospective Studies; Treatment Failure; Trimethoprim Resistance | 2015 |
Efficacy of Appropriate Antimicrobial Therapy on the Survival of Patients With Carbapenem Nonsusceptible Klebsiella Pneumoniae Infection: A Multicenter Study in Taiwan.
Topics: Aged; Anti-Infective Agents; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Medication Therapy Management; Meropenem; Microbial Sensitivity Tests; Middle Aged; Outcome Assessment, Health Care; Pneumonia; Proportional Hazards Models; Severity of Illness Index; Taiwan; Thienamycins | 2015 |
In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Cefepime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Taiwan; Thienamycins | 2016 |
Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Colistin; Enzyme-Linked Immunosorbent Assay; Imipenem; Interleukin-10; Lysophosphatidylcholines; Mice; Microbial Sensitivity Tests; Minocycline; Pneumonia; Sepsis; Tigecycline; Tumor Necrosis Factor-alpha | 2016 |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome | 2016 |
Photo Quiz: A 44-Year-Old Kidney Transplant Patient with Pneumonia.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Clostridioides difficile; Enterobacter cloacae; Female; Humans; Imipenem; Kidney Failure, Chronic; Kidney Transplantation; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Respiratory Insufficiency; Vancomycin | 2017 |
Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Lung Transplantation; Male; Minocycline; Pneumonia; Risk Factors; Tigecycline; Treatment Outcome | 2008 |
Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Rectum; Stenotrophomonas maltophilia; Thienamycins | 2011 |
Imipenem-induced Clostridium difficile diarrhea in a patient with chronic renal failure.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Imipenem; Kidney Failure, Chronic; Male; Pneumonia; Vancomycin | 2011 |
[A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone].
Topics: Acinetobacter; Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gastritis; Gastroparesis; Gastroscopy; Humans; Imipenem; Klebsiella oxytoca; Male; Ofloxacin; Pneumonia; Tomography, X-Ray Computed | 2011 |
Efficacy of methylprednisolone in children with severe community acquired pneumonia.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Female; Humans; Imipenem; Male; Methylprednisolone; Pneumonia | 2013 |
Response to letter.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Female; Humans; Imipenem; Male; Methylprednisolone; Pneumonia | 2013 |
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Pneumonia; Prospective Studies; Renal Insufficiency; Ventilators, Mechanical | 2003 |
[Inflammatory response in pneumonia: are glucocorticosteroids useful?].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacterial Proteins; Carrier Proteins; Cytokines; Hexosyltransferases; Humans; Imipenem; Interleukins; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia; Protein C; Steroids; Tumor Necrosis Factor-alpha | 2003 |
[Characteristics of bacteriology and drug sensitivity in patients with COPD combined with pneumonia].
Topics: Adult; Aged; Amikacin; Bacteria; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Vancomycin | 2003 |
Successful therapy of severe pneumonia-associated ARDS after pneumonectomy with ECMO and steroids.
Topics: Anti-Inflammatory Agents; Bronchial Fistula; Carcinoma, Bronchogenic; Cilastatin; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Extracorporeal Membrane Oxygenation; Humans; Hypoxia; Imipenem; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Pneumonectomy; Pneumonia; Positive-Pressure Respiration; Postoperative Complications; Reoperation; Respiratory Distress Syndrome | 2004 |
Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Carbapenems; Cross Infection; Histocytochemistry; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pneumonia; Thienamycins | 2004 |
Imipenem/cilastatin as monotherapy in the treatment of acute or chronic lung infections: clinical efficacy and safety.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Safety | 1989 |
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.
Topics: Acinetobacter Infections; Analysis of Variance; Anti-Bacterial Agents; Chi-Square Distribution; Colistin; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Retrospective Studies; Risk Factors; Thienamycins; Ventilators, Mechanical | 2007 |
Alpha-MSH promotes spontaneous post-ischemic pneumonia in mice via melanocortin-receptor-1.
Topics: Agouti Signaling Protein; alpha-MSH; Animals; Anti-Bacterial Agents; B-Lymphocytes; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Imipenem; Infarction, Middle Cerebral Artery; Lung; Macrophages; Male; Mice; Mice, Inbred C57BL; Pneumonia; Radioimmunoassay; Receptor, Melanocortin, Type 1; Spleen; T-Lymphocytes; Up-Regulation | 2008 |
A pharmacodynamic simulation to assess tigecycline efficacy for hospital-acquired pneumonia compared with other common intravenous antibiotics.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Models, Biological; Monte Carlo Method; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Tigecycline | 2008 |
Successful treatment of legionella pneumonia with imipenem.
Topics: Anti-Bacterial Agents; Humans; Imipenem; Legionnaires' Disease; Pneumonia; Thienamycins | 1984 |
Comparative activities of N-formimidoyl thienamycin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Bacterial Agents; Guinea Pigs; Imipenem; Male; Penicillins; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Ticarcillin; Tobramycin | 1982 |
[Rhodococcus equi pneumonia in patients with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Actinomycetales Infections; Adult; Clarithromycin; Erythromycin; Humans; Imipenem; Male; Middle Aged; Pneumonia; Rhodococcus equi; Rifampin; Vancomycin | 1994 |
[Pleural empyema caused by Corynebacterium sp].
Topics: Aged; Clindamycin; Community-Acquired Infections; Corynebacterium Infections; Drainage; Empyema, Pleural; Humans; Imipenem; Male; Pneumonia; Thoracic Duct | 1995 |
Successful treatment of concomitant pulmonary nocardiosis and aspergillosis in an immunocompromised renal patient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclophosphamide; Drug Therapy, Combination; Humans; IgA Vasculitis; Imipenem; Immunocompromised Host; Itraconazole; Ketoconazole; Kidney Failure, Chronic; Lung; Lung Diseases, Fungal; Male; Nocardia Infections; Pneumonia; Prednisolone; Radiography; Renal Dialysis; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
The effects of experimental splenic autotransplantation and imipenem-cilastatin treatment in postsplenectomy Pseudomonas aeruginosa sepsis.
Topics: Animals; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Hemoglobins; Imipenem; Immunoglobulin M; Lung; Male; Oxygen; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Sepsis; Spleen; Splenectomy; Transplantation, Autologous | 1995 |
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination; Fluconazole; Fusidic Acid; Humans; Imipenem; Immunocompromised Host; Male; Methicillin Resistance; Nocardia Infections; Pneumonia; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 1996 |
[Systemic Nocardia asteroides infection with endocardial involvement in a patient undergoing immunosuppressive therapy].
Topics: Anti-Bacterial Agents; Brain Diseases; Cilastatin; Cyclosporine; Doxycycline; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Eye Infections, Bacterial; Fatal Outcome; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Nocardia asteroides; Nocardia Infections; Pneumonia; Protease Inhibitors; Status Epilepticus; Thienamycins | 1996 |
Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Pneumonia; Rats; Rats, Wistar; Thienamycins | 1998 |
Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains.
Topics: Acinetobacter; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Disease Models, Animal; Endocarditis; Heart Valves; Imipenem; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia; Rabbits; Sulbactam; Survival Rate; Time Factors | 2001 |
Antibiotic resistance and virulence properties of Pseudomonas aeruginosa strains from mechanically ventilated patients with pneumonia in intensive care units: comparison with imipenem-resistant extra-respiratory tract isolates from uninfected patients.
Topics: Bacterial Adhesion; beta-Lactam Resistance; Cells, Cultured; Critical Care; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; France; Humans; Imipenem; O Antigens; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Random Amplified Polymorphic DNA Technique; Respiration, Artificial; Statistics, Nonparametric; Thienamycins; Virulence | 2002 |
Mediastinal abscess and pneumonia of dental origin.
Topics: Abscess; Adult; Cilastatin; Focal Infection, Dental; Humans; Imipenem; Male; Mediastinal Diseases; Neck; Penicillins; Periapical Abscess; Pneumonia; Streptococcal Infections; Streptococcus | 1992 |
Imipenem/teicoplanin for Rhodococcus equi pulmonary infection in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Actinomycetales Infections; Adult; Drug Therapy, Combination; Glycopeptides; Humans; Imipenem; Male; Pneumonia; Rhodococcus; Teicoplanin | 1991 |
Novel resistance to imipenem associated with an altered PBP-4 in a Pseudomonas aeruginosa clinical isolate.
Topics: Animals; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Drug Resistance, Microbial; Hexosyltransferases; Imipenem; Membrane Proteins; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 1990 |
Seizure activity with imipenem therapy: incidence and risk factors.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Humans; Imipenem; Joint Diseases; Knee Joint; Male; Pneumonia; Risk Factors; Seizures | 1990 |
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gentamicins; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Mice, Inbred ICR; Muscles; Pneumonia | 1989 |
[Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Cyclopropanes; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Thienamycins | 1986 |
Imipenem/cilastatin in the treatment of severe nosocomial pneumonia.
Topics: Adolescent; Adult; Aged; Cilastatin; Cross Infection; Dipeptidases; Drug Combinations; Drug Evaluation; Female; Humans; Imipenem; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia | 1988 |
Imipenem-cilastatin. A new dimension.
Topics: Adolescent; Adult; Aged; Cilastatin; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia | 1988 |
[Clinical and pharmacokinetic evaluation of imipenem/cilastatin sodium in children].
Topics: Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Humans; Imipenem; Infant; Infusions, Intravenous; Kinetics; Pneumonia; Sepsis; Thienamycins; Thyroiditis; Urinary Tract Infections | 1986 |
Nosocomial and nursing home-acquired pneumonia. Recent therapeutic advances.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cilastatin; Clavulanic Acid; Clavulanic Acids; Cross Infection; Cyclopropanes; Humans; Imipenem; Nursing Homes; Pneumonia; Thienamycins; Ticarcillin | 1987 |
Imipenem/cilastatin as secondary therapy for infections in cancer patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Cyclopropanes; Dipeptidases; Female; Humans; Imipenem; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutrophils; Pneumonia; Sepsis; Thienamycins | 1986 |
Clinical outcome of nosocomial pneumonia following imipenem/cilastatin therapy.
Topics: Adult; Cilastatin; Cross Infection; Cyclopropanes; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Thienamycins | 1987 |
[Calculated initial chemotherapy in mechanically-ventilated postoperative patients with peritonitis, sepsis and pneumonia].
Topics: Adult; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Pneumonia; Postoperative Complications; Respiration, Artificial; Retrospective Studies; Sepsis; Thienamycins | 1986 |
Pneumonia treated with imipenem/cilastatin.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cilastatin; Cross Infection; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Pseudomonas Infections; Thienamycins | 1985 |
Treatment of pneumonia with imipenem/cilastatin.
Topics: Adult; Aged; Cilastatin; Cyclopropanes; Dipeptidases; Drug Combinations; Female; Hospitalization; Humans; Imipenem; Infusions, Parenteral; Legionnaires' Disease; Male; Middle Aged; Pilot Projects; Pneumonia; Thienamycins | 1985 |
Primaxin in the treatment of acute bacterial pneumonia in adults.
Topics: Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Dipeptidases; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Thienamycins | 1985 |